Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination

Vaccine

Volumn 29, Issue 7, 2011, Pages 1438-1442

  de Carvalho, Camila Xavier ^a   Kipnis, André ^a   Thörn, Licia ^b   de Andrade, João Guimarães ^a   Pimenta, Fabiana ^c   Brandileone, Maria Cristina de Cunto ^d   Zanella, Rosemeire Cobo ^d   Flannery, Brendan ^e   Sgambatti, Sabrina ^f   Andrade, Ana Lucia ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Division of Epidemiology   (Brazil)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d INSTITUTO ADOLFO LUTZ   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^f Catolica University of Goiás   (Brazil)

Author keywords

H. influenzae carriage; Hib vaccination; Nontypeable H. influenzae

Indexed keywords

BETA LACTAMASE TEM 1;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; DAY CARE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; INFANT; INFLUENZA VACCINATION; MALE; NASOPHARYNX; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; BETA-LACTAMASES; BRAZIL; CARRIER STATE; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INFANT; MALE; NASOPHARYNX; OTITIS MEDIA; PREVALENCE;

EID: 79151471053     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.045     Document Type: Article

References (46)

1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000, 13(2):302-317.
2. Bisgard K.M., Kao A., Leake J., Strebel P.M., Perkins B.A., Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine preventable childhood disease. Emerg Infect Dis 1998, 4(2):229-237.
3. Nizet V., Colina K.F., Almquist J.R., Rubens C.E., Smith A.L. A virulent nonencapsulated Haemophilus influenzae. J Infect Dis 1996, 173(1):180-186.
4. Adam H.J., Richardson S.E., Jamieson F.B., Rawte P., Fisman D.N. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010, 28(24):4073-4078.
5. Ladhani S., Slack M.P.E., Heath P.T., von Gottberg A., Chandra M., Ramsay M.E., et al. Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infec Dis 2010, 16(3):455-463.
6. Morris S.K., Moss J.W., Halsey N. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infec Dis 2008, 8(7):435-443.
7. Simões L.L., Andrade A.L., Laval C.A., Oliveira R.M., Silva S.A., Martelli C.M., et al. Impact of Haemophilus influenzae b (Hib) vaccination on meningitis in Central Brazil. Rev Saude Publica 2004, 38(5):664-670.
8. Miranzi Sde S., de Moraes S.A., de Freitas I.C. Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil. Cad Saude Publica 2007, 23(7):1689-1695.
9. Barbour M., Phil D. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 1996, 2(3):176-182.
10. Dworkin M.S., Park L., Borchardt S.M. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or =65 years old. Clin Infect Dis 2007, 44(6):810-816.
11. Faden H., Duffy L., Williams A., Krystofik D.A., Wolf J. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life. J Infect Dis 1995, 172(1):132-135.
12. Harabuchi Y., Faden H., Yamanaka N., Duffy L., Wolf J., Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J Infect Dis 1994, 170(4):862-866.
13. Peerbooms P.G., Engelen M.N., Stokman D.A., van Benthem B.H., van Weert M.L., Bruisten S.M., et al. Nasopharyngeal carriage of potential bacterial pathogens related to day care attendance, with special reference to the molecular epidemiology of Haemophilus influenzae. J Clin Microbiol 2002, 40(8):2832-2836.
14. Dabernat H., Plisson-Sauné M.A., Delmas C., Séguy M., Faucon G., Pélissier R., et al. Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study. J Clin Microbiol 2003, 41(4):1664-1672.
15. Dagan R., Frasch C. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction. Pediatr Infect Dis J 2009, 28(4 Suppl.):S63-S65.
16. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006, 367(9512):740-748.
17. Prymula R., Kriz P., Kaliskova E., Pascal T., Poolman J., Schuerman L. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 2009, 28(1):71-78.
18. Franco C.M., Andrade A.L., Andrade J.G., Almeida e Silva S., Oliveira R.M., Pimenta F.C., et al. Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day-care centers in Brazil. Pediatr Infect Dis J 2010, 29(1):77-79.
19. Bou R., Dominguez A., Fontanals D., Sanfeliu I., Pons I., Renau J., et al. Prevalence of Haemophilus influenzae pharyngeal carriers in the school population of Catalonia. Working Group on invasive disease caused by Haemophilus influenzae. Eur J Epidemiol 2000, 16(6):521-526.
20. World Health Organization & Centers for Disease Control and Prevention. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. Available from: [accessed June 10, 2010]. http://www.who.int/csr/resources/publications/meningitis/whocdscsredc997.pdf.
21. Ministério da Saúde do Brasil. DATASUS. Informações de Saúde. Imunizações-Doses Aplicadas; 2007. Available at: [accessed July 5, 2010]. http://tabnet.datasus.gov.br/cgi/deftohtm.exe%3Fpni/cnv/dpnigo.def.
22. van Ketel R.J., de Wever B., van Alphen L. Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification. J Med Microbiol 1990, 33(4):271-276.
23. Falla T.J., Crook D.W.M., Brophy L.N., Maskell D., Kroll J.S., Moxon E.R. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994, 32(10):2382-2386.
24. St Geme J.W., Falkow S. Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect Immun 1991, 59(4):1325-1333.
25. Tenover F.C., Mohammed M.J., Gorton T.S., Dembek Z.F. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 1999, 37(12):4065-4070.
26. Farrell D.J., Morrissey I., Bakker S., Buckridge S., Felmingham D.G.R. Global distribution of TEM-1 and ROB-1 b-lactamases in Haemophilus influenzae. J Antimicrob Chemother 2005, 56(4):773-776.
27. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley, John & Sons, [incorporated, 672 pp.]. 2nd ed.
28. Barbosa-Cesnik C., Farjo R., Patel M., Gilsdorf J., McCoy S.I., Pettigrew M., et al. Predictors for Haemophilus influenzae colonization, antibiotic resistance and for sharing an identical isolate among children attending 16 licensed day-care centers in Michigan. Pediatr Infect Dis J 2006, 25(3):219-223.
29. Laval C.B., Andrade A.L., Pimenta F.C., Andrade J.G., Oliveira R.M., Silva S.A., et al. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines. Clin Microbiol Infect 2006, 12(1):50-55.
30. Bokermann S., Zanella R.C., Lemos A.P., de Andrade A.L., Brandileone M.C. Evaluation of methodology for serotyping invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil. J Clin Microbiol 2003, 41(12):5546-5550.
31. Scriver S.R., Walmsley S.L., Kau C.L., Hoban D.J., Brunton J., McGeer A., et al. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their b-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother 1994, 38(7):1678-1680.
32. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004, 23(9):829-833.
33. Dagan R., Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect Dis 2002, 2(10):593-604.
34. McEllistrem M.C., Adams J.M., Patel K., Mendelsohn A.B., Kaplan S.L., Bradley J.S., et al. Acute otitis media due to penicillin nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2005, 40(12):1738-1744.
35. Casey J.R., Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004, 23(9):824-828.
36. Pichichero M.E. Evolving shifts in otitis media pathogens: relevance to a managed care organization. Am J Manag Care 2005, 11:S192-201.
37. McCaig L.F., Besser R.E., Hughes J.M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002, 287(23):3096-3102.
38. Grijalva C.G., Nuorti J.P., Griffin M.R. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009, 302(7):758-766.
39. Forleo-Neto E., Oliveira C.F., Maluf E.M.C.P., Bataglin C., Araújo J.M.R., Kunz L.F., et al. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with Hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine. J Infect Dis 1999, 180(4):1153-1158.
40. Bricks L.F., Mendes C.M.F., Lucarevschi B.R., Oplustil C.P., Zanella R.C., Bori A., et al. Oropharyngeal colonization by Haemophilus influenzae in healthy children from Taubaté (São Paulo), prior to the Haemophilus influenzae type b vaccination program in Brazil. Rev Hosp Clin Fac Med Sao Paulo 2004, 59(5):236-243.
41. Ministério da Saúde do Brasil. DATASUS. Informações de Saúde. Imunizações-Doses Aplicadas; 2007. Available at: [accessed in July 5, 2010]. http://tabnet.datasus.gov.br/cgi/deftohtm.exe%3Fpni/cnv/dpnigo.def.
42. Heath P.T., Booy R., Azzopardi H.J., Slack M.P., Fogarty J., Moloney A.C., et al. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J 2001, 20(3):300-305.
43. Murphy T.V., Pastor P., Medley F., Osterholm M.T., Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993, 122(4):517-523.
44. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. J Infect Dis 1998, 177(6):1758-1761.
45. Rushdy A., Ramsay M., Heath P.T., Azzopardi H.J., Slack M.P. Infant Hib vaccination and herd immunity. J Pediatr 1999, 134(2):253-254.
46. Urwin G., Krohn J.A., Deaver-Robinson K., Wenger J.D., Farley M.M. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clin Infect Dis 1996, 22(6):1069-1076.